Association between disease activity, arterial stiffness, and 10-year cardiovascular risk in patients with rheumatoid arthritis: a cross-sectional study.
Senning Liu, Ming Jiang, Mengjiao Zhang, Zhenyi Li, Hanwen Tong, Hairong Wang, Panpan Hu, Wenling Fang, Rong Yu, Tianyu Wu, Lin Jin, Zhaojun Li
{"title":"Association between disease activity, arterial stiffness, and 10-year cardiovascular risk in patients with rheumatoid arthritis: a cross-sectional study.","authors":"Senning Liu, Ming Jiang, Mengjiao Zhang, Zhenyi Li, Hanwen Tong, Hairong Wang, Panpan Hu, Wenling Fang, Rong Yu, Tianyu Wu, Lin Jin, Zhaojun Li","doi":"10.1007/s00296-026-06274-2","DOIUrl":null,"url":null,"abstract":"<p><p>Patients with rheumatoid arthritis (RA) are at increased cardiovascular risk. This study explored the association of RA disease activity with arterial stiffness (AVI) and 10-year atherosclerotic cardiovascular disease (ASCVD) risk. This retrospective cross-sectional study enrolled 1,152 RA patients (484 inactive, 668 active, no prior cardiovascular/cerebrovascular disease) and 235 healthy controls. Clinical characteristics, laboratory parameters, and AVI were compared among groups. Multivariable logistic regression was performed to identify factors independently associated with high AVI. The interaction between disease activity and disease duration on AVI was also assessed using two-way analysis of variance (two-way ANOVA). AVI levels and high AVI prevalence were significantly higher in active RA patients than in inactive RA and controls (p < 0.05). With increasing disease activity, Disease Activity Score 28 based on C-reactive protein (DAS28-CRP), C-reactive protein (CRP), and erythrocyte sedimentation rate increased significantly (all p < 0.001). Multivariable regression showed that systolic blood pressure (OR = 1.025, 95% CI 1.010-1.040), moderate disease activity (OR = 4.932, 95% CI 1.018-23.900), and high disease activity (OR = 6.342, 95% CI 1.239-32.475) were independently associated with high AVI. Two-way ANOVA indicated that disease activity had a significant main effect on AVI (F = 5.343, p < 0.001), whereas disease duration and its interaction with disease activity were not significant. RA disease activity is closely associated with increased arterial stiffness and higher estimated 10-year ASCVD risk. In this cross-sectional cohort, disease activity was more strongly associated with AVI than disease duration.</p>","PeriodicalId":21322,"journal":{"name":"Rheumatology International","volume":"46 9","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2026-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rheumatology International","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00296-026-06274-2","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Patients with rheumatoid arthritis (RA) are at increased cardiovascular risk. This study explored the association of RA disease activity with arterial stiffness (AVI) and 10-year atherosclerotic cardiovascular disease (ASCVD) risk. This retrospective cross-sectional study enrolled 1,152 RA patients (484 inactive, 668 active, no prior cardiovascular/cerebrovascular disease) and 235 healthy controls. Clinical characteristics, laboratory parameters, and AVI were compared among groups. Multivariable logistic regression was performed to identify factors independently associated with high AVI. The interaction between disease activity and disease duration on AVI was also assessed using two-way analysis of variance (two-way ANOVA). AVI levels and high AVI prevalence were significantly higher in active RA patients than in inactive RA and controls (p < 0.05). With increasing disease activity, Disease Activity Score 28 based on C-reactive protein (DAS28-CRP), C-reactive protein (CRP), and erythrocyte sedimentation rate increased significantly (all p < 0.001). Multivariable regression showed that systolic blood pressure (OR = 1.025, 95% CI 1.010-1.040), moderate disease activity (OR = 4.932, 95% CI 1.018-23.900), and high disease activity (OR = 6.342, 95% CI 1.239-32.475) were independently associated with high AVI. Two-way ANOVA indicated that disease activity had a significant main effect on AVI (F = 5.343, p < 0.001), whereas disease duration and its interaction with disease activity were not significant. RA disease activity is closely associated with increased arterial stiffness and higher estimated 10-year ASCVD risk. In this cross-sectional cohort, disease activity was more strongly associated with AVI than disease duration.
期刊介绍:
RHEUMATOLOGY INTERNATIONAL is an independent journal reflecting world-wide progress in the research, diagnosis and treatment of the various rheumatic diseases. It is designed to serve researchers and clinicians in the field of rheumatology.
RHEUMATOLOGY INTERNATIONAL will cover all modern trends in clinical research as well as in the management of rheumatic diseases. Special emphasis will be given to public health issues related to rheumatic diseases, applying rheumatology research to clinical practice, epidemiology of rheumatic diseases, diagnostic tests for rheumatic diseases, patient reported outcomes (PROs) in rheumatology and evidence on education of rheumatology. Contributions to these topics will appear in the form of original publications, short communications, editorials, and reviews. "Letters to the editor" will be welcome as an enhancement to discussion. Basic science research, including in vitro or animal studies, is discouraged to submit, as we will only review studies on humans with an epidemological or clinical perspective. Case reports without a proper review of the literatura (Case-based Reviews) will not be published. Every effort will be made to ensure speed of publication while maintaining a high standard of contents and production.
Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.